RE: well well well...29 Mar 2022 12:16
David Budd, CEO of genedrive plc, said: "We are grateful to NICE for their engagement and interest in our innovative technology and pleased that the Genedrive(R) MT-RNR1 tests was selected for a MIB review. This NICE MIB documentation, our cooperation with Inspiration Healthcare plc and the publication of the PALOH study results are all important components needed to successfully promote our innovative test for antibiotic induced hearing loss screening.